KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Debt Ratio (2016 - 2023)

Pacific Biosciences Of California has reported Debt Ratio over the past 13 years, most recently at 0.05 for Q3 2023.

  • Quarterly results put Debt Ratio at 0.05 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was 0.05 (changed N/A YoY), and the annual figure for FY2022 was 0.1, up 4915.96%.
  • Debt Ratio for Q3 2023 was 0.05 at Pacific Biosciences Of California, down from 0.1 in the prior quarter.
  • Over the last five years, Debt Ratio for PACB hit a ceiling of 0.11 in Q4 2019 and a floor of 0.0 in Q4 2021.
  • Median Debt Ratio over the past 4 years was 0.1 (2022), compared with a mean of 0.08.
  • Biggest five-year swings in Debt Ratio: rose 24.02% in 2019 and later surged 4915.96% in 2022.
  • Pacific Biosciences Of California's Debt Ratio stood at 0.11 in 2019, then crashed by 98.18% to 0.0 in 2021, then surged by 4915.96% to 0.1 in 2022, then tumbled by 48.12% to 0.05 in 2023.
  • The last three reported values for Debt Ratio were 0.05 (Q3 2023), 0.1 (Q2 2023), and 0.1 (Q1 2023) per Business Quant data.